SDC1 and plasma cell myeloma: As illustrated in Figure 3, the first indication of a potential role of MM-EVs in promoting the dissemination of myeloma bone disease was reported by Zhang et al. who identified a correlation between peripheral blood CD138+ circulating EVs and bone lesions in de novo MM patients [13].